MOH Molina Healthcare Inc Common Stock
NYSE · Health Care · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Jul 23, 2026MOH Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
MOH Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 23 de mayo de 2011 | 3-for-2 | Adelante |
Acerca de Molina Healthcare Inc Common Stock Descripción general de la empresa de Wikipedia
Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.
History
Molina Healthcare was founded in 1980 by C. David Molina, an emergency room physician in Long Beach, California. He had seen an influx of patients using the emergency room for common illnesses such as a sore throat or the flu because they were being turned away by doctors who would not accept Medi-Cal. Molina established his first primary care clinic with the goal of treating the lowest-income patients, regardless of their ability to pay.
Leadership
For twenty years, the company was run by Dr. Molina's son, J. Mario Molina, MD, a physician. He was the president and CEO of the company. John Molina, Mario's younger brother, was the CFO of Molina Healthcare. The two took over Molina's operations after their father died in 1996 and continued to expand the company. In May 2017 Dr. J. Mario Molina and John Molina were removed from their positions by the Board of Directors, who cited poor financial performance as the reason for the change in leadership. Though the board also discused their displeasure in the CEO and CFO criticising President Donald Trump.[3][4] In October 2017 the company announced Joseph Zubretsky, the former CFO of Aetna, as Molina Healthcare's president and CEO.
Clinics
The first Molina Medical clinic was opened in Wilmington, California in 1980. The company formerly operated clinics in Washington, New Mexico, Florida and Utah. The clinics were opened to provide health care to low-income families and individuals. In August 2017 Molina Healthcare announced it would close several clinics in Michigan, Florida, New Mexico, Wisconsin, and Utah.
Becoming HMO
Molina Healthcare has focused on government-paid healthcare programs such as SCHIP and Medicaid since it became a health maintenance organization in 1985. From 1985 to 1997, the company was based solely in California.
Expansion of health plans
1997: Molina Healthcare acquires Health Reach Family Health Care and enters the states of Utah and Michigan.
2000: Molina Healthcare enters the state of Washington.
2004: Molina Healthcare enters the state of New Mexico.
2005: Molina Healthcare becomes a health plan in Ohio.
2006: Molina Healthcare enters the state of Texas.
2007: Molina Healthcare enters Missouri.
2008: Molina Healthcare enters Florida.
2010: Molina Healthcare enters Wisconsin.
2012: Molina Healthcare enters Illinois.
2013: Molina Healthcare enters South Carolina by acquiring assets from Community Health Solutions.
2013: Molina Healthcare acquires New Mexico Lovelace Medicaid contract.
2014: Molina Healthcare acquires Florida Medicaid assets from First Coast Advantage.
2015: Molina Healthcare enters Chicago market, acquiring MyCare Chicago's Medicaid assets.
2015: Molina Healthcare enters Puerto Rico.
2015: Molina Healthcare of Washington is the first health care company in the state to cover "Virtual Urgent Care" services.
2015: Molina Healthcare acquires Medicaid assets of Integral Health Plan, Inc. in Florida.
2015: Molina Healthcare acquires Providence Human Services and Community Services from Providence Service Corporation and renames them Pathways.
2015: Molina Healthcare adds online access to behavioral health.
2015: Molina Healthcare acquires HealthPlus MIChild and Medicaid programs of Michigan.
2015: Molina Healthcare acquires assets of Loyola Physician Partners' Medicaid Program of Illinois.
2017: Molina Healthcare exits the individual Marketplace in Utah and Wisconsin.
2018: Molina Healthcare loses Medicaid contract with the state of New Mexico.
2018: Molina Healthcare sells Pathways to Altar Capital
2019: Molina Healthcare loses Medicaid contract with the state of Texas.
2020: Molina Healthcare acquires Passport Health Plan in Kentucky.
2021: Molina Healthcare acquires Magellan Complete Care line of business from Magellan Health, Inc. With this acquisition, Molina enters Arizona, Massachusetts, and Virginia.
2021: Molina Healthcare acquires Affinity Health Plan in New York.
2021: Molina Healthcare acquires Cigna's Medicaid contracts in Texas.
2023: Molina Healthcare enters Iowa.
2023: Molina Healthcare loses Medicad contract with the state of Indiana.
2024: Molina Healthcare loses Medicaid contracts with the states of Virginia and Florida.
Going public
Molina Healthcare filed with the Securities and Exchange Commission for an initial stock offering in December 2002 and went public in July 2003 with a stock offering of $102 million. The shares were priced at $17.50, and Molina raised approximately $124 million in the initial public offering. In its stock market debut, Molina sold 6.6 million shares at $20.30, making the company the third-best first day gainer of 2003. Molina Healthcare was the first company from Inc. Magazine's "Inner City 100" list to go public.
Entering the Medicare market
Molina Healthcare entered the Medicare market in 2006. The company currently offers Medicare health plan options in: Arizona, California, Florida, Idaho, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Mexico, New York, Ohio, South Carolina, Texas, Utah, Virginia, Washington and Wisconsin.
Entering MMIS market
Molina Healthcare acquired Unisys' health information management business in December 2010 to create Molina Medicaid Solutions (MMS). MMS has Medicaid Management Information Systems (MMIS) contracts with Idaho, Louisiana, Maine, New Jersey, West Virginia and the U.S. Virgin Islands. In Autumn 2018, Molina Healthcare, Inc. sold its Medicaid management information systems business, Molina Medicaid Solutions (MMS), to DXC Technology. MMS was a wholly owned subsidiary of Molina Healthcare at the time of sale.
Entering health insurance marketplace
In 2014, Molina Healthcare began offering Marketplace plans in nine states where it offered Medicaid health plans through State Facilitated Marketplaces and Federally Facilitated Marketplace. On November 16, 2016 the Seattle Times reported that about 11 million people currently get their coverage through the exchange. In August 2017 Molina announced it would stop offering plans on the health insurance marketplaces in Utah, Wisconsin, and Maine in 2018.
Dual eligible demonstration projects
Molina was selected to participate in dual eligible demonstration projects in California, Ohio, Illinois, Michigan, South Carolina and Texas to serve patients who are eligible for both Medicare and Medicaid.
Criticism and controversies
A 2023 report investigating "High Rates of Prior
Authorization Denials" reported that Molina Healthcare's Medicaid plans for financially vulnerable people had some of the highest denial percentages in the country. It was reported, that Molina Healthcare operated plans that denied medical care under requests for prior authorization of services in more than 25% of cases in 2019. About 2.7 million people were enrolled in these plans at the time, while another 8.4 million people were enrolled in plans with denial rates higher than average at 15-25%. Some plans had even higher denial rates, as their Illinois plan 41% of requests.
Philanthropy
In May 2022, MolinaCares presented a $100,000 grant to support Compass Health's Broadway Campus Redevelopment Project. The grant will aid funding of construction of a 72,000 square-foot, state-of-the-art facility that will expand community-based behavioural health care services and its workforce in northwest Washington.
In August 2026, MolinaCares awarded a grant of $150,000 to literacy non-profit Indy Reads, to launch a new program in health literacy, in partnership with Molina Healthcare.
Awards and recognition
Molina Healthcare was awarded the 2011 Alfred P. Sloan Award for Business Excellence in Workplace Flexibility. The award ranked Molina Healthcare in the top 20 percent of employers nationally in terms of its programs, policies and culture for creating an effective and flexible workplace. In 2006, Molina Healthcare was named among the 100 best corporate citizens by Business Ethics magazine. In 2005, Time magazine recognized Dr. J. Mario Molina, then CEO of Molina Healthcare, as one of the 25 most influential Hispanics in America.
The company ranked 155th on the 2021 Fortune 500 list of the largest United States corporations by revenue. The company ranked 126th on the 2023 Fortune 500 list of the largest United States corporations by revenue.
Other awards and recognition
2014: Milwaukee Journal Sentinel Recognizes Molina Healthcare of Wisconsin with a Top Workplace Award 2014
2014: Molina Healthcare of New Mexico voted Best Places to Work by Albuquerque Business First
2014: Molina Healthcare was one of 26 companies to participate in President Obama's SupplierPay 2014
2015: Molina Healthcare voted Top Ten Least Stressful Companies to Work for In America 2015
2015: Molina Healthcare ranked 301 in top Fortune 500 2015
2016: Molina Healthcare ranked 201 in top Fortune 500 2016
2017: Molina Healthcare ranked 156 in Fortune 500 2017
2023: Molina Healthcare of Kentucky awarded One of Kentucky's Best Places to Work
2023: Molina Healthcare recognized as one of America's Best-in-State Employers by Forbes
2023: Molina Healthcare recognized as one of Time's World's Best Companies of 2023
2023: Molina Healthcare recognized as one of Newsweek's Greatest Workplaces for Parents and Families 2023
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | MOH | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | 1053.0promedio 5A ≈21.1 | ≈21.1 | 36.3 | Sobrevalorado | |
| P/S (TTM) | 0.2promedio 5A ≈0.5 | ≈0.5 | 0.7 | Infravalorado | |
| P/C (MRQ) | 2.4promedio 5A ≈4.3 | ≈4.3 | 3.9 | Infravalorado | |
| EV / EBITDA (TTM) | 12.7promedio 5A ≈7.0 | ≈7.0 | 16.1 | Infravalorado | |
| Precio / FCF (TTM) | 36.4promedio 5A ≈14.4 | ≈14.4 | · | · | |
| Precio / Flujo de Caja (TTM) | 27.0promedio 5A ≈11.5 | ≈11.5 | · | · | |
| EV / Ingresos (TTM) | 0.1promedio 5A ≈0.3 | ≈0.3 | · | · | |
| EV / FCF (TTM) | 17.4promedio 5A ≈10.3 | ≈10.3 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 5.3promedio 5A ≈7.7 | ≈7.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | MOH | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | 0.46%promedio 5A ≈3.6% | ≈3.6% | 3.5% | Débil | |
| Margen EBITDA (TTM) | 0.83%promedio 5A ≈4.1% | ≈4.1% | 3.7% | Débil | |
| Margen antes de impuestos (TTM) | -0.01%promedio 5A ≈3.2% | ≈3.2% | 2.8% | Débil | |
| Margen de Beneficio Neto (TTM) | -0.02%promedio 5A ≈2.4% | ≈2.4% | 2.9% | Débil | |
| ROA (TTM) | -0.04%promedio 5A ≈6.3% | ≈6.3% | 3.0% | En línea | |
| ROE (TTM) | -0.16%promedio 5A ≈23.1% | ≈23.1% | 10.1% | En línea | |
| ROIC | 8.0%promedio 5A ≈15.3% | ≈15.3% | 8.0% | En línea |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | MOH | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.9promedio 5A ≈0.7 | ≈0.7 | 0.7 | Deuda alta | |
| Ratio corriente (MRQ) | 1.7promedio 5A ≈1.5 | ≈1.5 | 1.7 | En línea | |
| Ratio Rápido (MRQ) | 1.6promedio 5A ≈1.5 | ≈1.5 | 1.3 | Liquidez sólida | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 0.9promedio 5A ≈0.7 | ≈0.7 | 0.7 | Deuda alta |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | MOH | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 11.8%promedio 5A ≈19.1% | ≈19.1% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 12.4%promedio 5A ≈15.5% | ≈15.5% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | 18.5% | · | · | · | |
| EPS YoY (EPS interanual) | -56.3%promedio 5A ≈2.3% | ≈2.3% | · | · | |
| Net Income YoY (Beneficio Neto interanual) | -60.0%promedio 5A ≈0.79% | ≈0.79% | · | · | |
| EPS CAGR 3Y (CAGR BPA 3A) | -13.0%promedio 5A ≈9.2% | ≈9.2% | · | · | |
| EPS CAGR 5Y (CAGR BPA 5A) | -4.5% | · | · | · | |
| Net Income CAGR 3Y (CAGR Beneficio Neto 3A) | -15.8%promedio 5A ≈7.7% | ≈7.7% | · | · | |
| Net Income CAGR 5Y (CAGR Beneficio Neto 5A) | -6.9% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | MOH | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 2.9promedio 5A ≈2.6 | ≈2.6 | 2.4 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 13.3promedio 5A ≈13.5 | ≈13.5 | 16.3 | Por debajo del promedio | |
| Revenue / Employee (Ingresos / Empleado) | ≈$2.4M | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Jul 21, 2026 | $1.51 | $1.40 | 7.5% |
| 31 de marzo de 2026 | $2.35 | $1.94 | 21.0% | |
| 31 de diciembre de 2025 | $-2.75 | $0.34 | -916.0% | |
| 30 de septiembre de 2025 | $1.84 | $3.94 | -53.3% | |
| 30 de junio de 2025 | $5.48 | $5.85 | -6.3% | |
| 31 de marzo de 2025 | $6.08 | $6.02 | 1.1% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Cost of Revenue | $39.49B | $34.43B | $28.67B | $27.18B | $23.70B | $15.82B | $13.90B | · | · | · | · | · | |
| Gross Profit | · | · | · | · | · | $2.48B | $2.30B | $2.52B | $1.81B | $1.73B | $1.53B | $1.00B | |
| SG&A Expense | $3.01B | $2.74B | $2.46B | $2.31B | $2.07B | $1.48B | $1.30B | $1.33B | $1.59B | $1.39B | $1.15B | $765M | |
| Operating Expenses | $44.65B | $38.94B | $32.50B | $30.80B | $26.75B | $18.34B | $15.79B | $17.76B | $20.44B | $17.48B | $13.79B | $9.47B | |
| Operating Income | $781M | $1.71B | $1.57B | $1.17B | $1.02B | $1.08B | $1.04B | $1.13B | $-555M | $306M | $387M | $193M | |
| Interest Expense | · | · | $109M | $110M | $120M | $102M | $87M | $115M | $118M | $101M | $66M | $57M | |
| Interest Income | · | · | · | $75M | $77M | $17M | $17M | $125M | $70M | $38M | $23M | $20M | |
| Other Non-op | · | · | $0 | $0 | $-25M | $-15M | $15M | $-17M | $61M | $0 | $1M | $-1M | |
| Pretax Income | $589M | $1.59B | $1.46B | $1.06B | $875M | $961M | $972M | $999M | $-612M | $205M | $322M | $135M | |
| Income Tax | $117M | $410M | $373M | $271M | $216M | $288M | $235M | $292M | $-100M | $153M | $179M | $73M | |
| Net Income | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| EPS (Basic) | $8.93 | $20.52 | $18.91 | $13.72 | $11.40 | $11.40 | $11.85 | $11.57 | $-9.07 | $0.93 | $2.75 | $1.33 | |
| EPS (Diluted) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 | |
| Shares (Basic) | 52,800,000 | 57,400,000 | 57,700,000 | 57,800,000 | 57,800,000 | 59,000,000 | 62,200,000 | 61,000,000 | 56,000,000 | 55,400,000 | 52,000,000 | 47,000,000 | |
| Shares (Diluted) | 52,900,000 | 57,700,000 | 58,100,000 | 58,500,000 | 58,600,000 | 59,900,000 | 64,200,000 | 67,000,000 | 56,000,000 | 56,000,000 | 56,000,000 | 48,000,000 | |
| EBITDA | $976M | $1.89B | $1.74B | $1.35B | $1.15B | $1.17B | $1.13B | $1.26B | $-377M | $488M | $513M | $327M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.25B | $4.66B | $4.85B | $4.01B | $4.44B | $4.15B | $2.45B | $2.83B | $3.19B | $2.82B | $2.33B | $1.54B | |
| Short-term Investments | $4.01B | $4.33B | $4.26B | $3.50B | $3.20B | $1.88B | $1.95B | $1.68B | $2.52B | $1.76B | $1.80B | $1.02B | |
| Receivables | $3.53B | $3.30B | $3.10B | $2.30B | $2.18B | $1.67B | $1.41B | $1.33B | $871M | $974M | $597M | $596M | |
| Prepaid Expense | $655M | $487M | $331M | $277M | $247M | $175M | $163M | $149M | $239M | $131M | $192M | $49M | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $51M | |
| Current Assets | $12.44B | $12.77B | $12.54B | $10.08B | $10.06B | $7.88B | $5.97B | $6.46B | $7.51B | $5.99B | $5.31B | $3.20B | |
| PP&E (Net) | · | · | · | · | · | · | · | $241M | $342M | $454M | $393M | $341M | |
| PP&E (Gross) | $1.11B | $1.03B | $932M | $882M | $822M | $752M | $687M | $774M | $883M | $919M | $755M | $618M | |
| Accum. Depreciation | $875M | $806M | $729M | $695M | $632M | $577M | $530M | $533M | $541M | $465M | $362M | $277M | |
| Goodwill | $1.96B | $1.67B | $1.24B | $1.11B | $982M | $692M | $143M | $143M | $186M | $620M | $519M | $272M | |
| Intangibles | $237M | $267M | $208M | $275M | $270M | $249M | $29M | $47M | $69M | $140M | $122M | $89M | |
| Other Non-current Assets | $147M | $138M | $143M | $123M | $179M | $119M | $105M | $24M | $141M | $41M | $28M | $30M | |
| Total Assets | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Accounts Payable | $1.09B | $1.33B | $1.25B | $889M | $842M | $641M | $502M | $390M | $366M | $385M | $362M | $242M | |
| Current Liabilities | $7.37B | $7.90B | $8.17B | $6.86B | $7.05B | $4.96B | $3.27B | $4.25B | $5.56B | $4.57B | $3.82B | $2.17B | |
| Capital Leases | $56M | $68M | $85M | $77M | $99M | $42M | $48M | $197M | $198M | $198M | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $15M | $0 | $24M | |
| Other Non-current Liabilities | $173M | $120M | $124M | $104M | $140M | $119M | $90M | $44M | $61M | $42M | $37M | $34M | |
| Total Liabilities | $11.49B | $11.13B | $10.68B | $9.35B | $9.58B | $7.44B | $4.83B | $5.51B | $7.13B | $5.80B | $5.02B | $3.42B | |
| Long-term Debt | · | · | · | · | · | $2.13B | $1.25B | · | · | $1.65B | $1.41B | $690M | |
| Total Debt | $3.77B | $2.92B | $2.18B | $2.18B | $2.17B | $2.13B | $1.24B | $1.02B | $1.32B | $1.65B | $449M | $341.0K | |
| Retained Earnings | $3.60B | $4.09B | $3.89B | $2.80B | $2.40B | $1.86B | $1.78B | $1.01B | $298M | $810M | $758M | $615M | |
| AOCI | $15M | $-57M | $-82M | $-160M | $-5M | $37M | $4M | $-8M | $-5M | $-2M | $-4M | $-1M | |
| Stockholders' Equity | $4.07B | $4.50B | $4.21B | $2.96B | $2.63B | $2.10B | $1.96B | $1.65B | $1.34B | $1.65B | $1.56B | $1.01B | |
| Liabilities + Equity | $15.56B | $15.63B | $14.89B | $12.31B | $12.21B | $9.53B | $6.79B | $7.15B | $8.47B | $7.45B | $6.58B | $4.43B | |
| Shares Outstanding | 51,000,000 | 56,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 59,000,000 | 62,000,000 | 62,000,000 | 60,000,000 | 57,000,000 | 56,000,000 | 50,000,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $195M | $186M | $171M | $176M | $131M | $88M | $89M | $127M | $178M | $182M | $126M | $134M | |
| Stock-based Comp | $47M | $116M | $115M | $103M | $72M | $57M | $39M | $27M | $46M | $26M | $23M | $22M | |
| Deferred Tax | $43M | $53M | $-31M | $-66M | $-24M | $-19M | $10M | $-6M | $-94M | $22M | $-7M | $-2M | |
| Amort. of Intangibles | $91M | $82M | $85M | $77M | $49M | $15M | $18M | $21M | $31M | $32M | $17M | $18M | |
| Restructuring | · | · | · | · | · | · | · | $8M | $150M | · | · | · | |
| Other Non-cash | $-1.29B | $-890M | $316M | $-232M | $1.28B | $1.09B | $-448M | $-1.17B | $1.19B | $391M | $840M | $844M | |
| Operating Cash Flow | $-535M | $644M | $1.66B | $773M | $2.12B | $1.90B | $434M | $-314M | $804M | $673M | $1.12B | $1.06B | |
| CapEx | $101M | $100M | $84M | $91M | $77M | $74M | $57M | $30M | $86M | $176M | $132M | $115M | |
| Investing Cash Flow | $312M | $-464M | $-744M | $-790M | $-1.65B | $-400M | $-293M | $1.14B | $-1.06B | $-206M | $-1.42B | $-536M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | $689M | $123M | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $373M | $0 | |
| Stock Repurchased | $1.00B | $1.00B | $0 | $400M | $128M | $606M | $47M | $0 | $0 | · | $0 | $0 | |
| Net Stock Activity | $-1.00B | $-1.00B | $0 | $-400M | $-128M | $-606M | $-47M | · | $0 | $0 | $373M | $0 | |
| Financing Cash Flow | $-170M | $-347M | $-58M | $-441M | $-183M | $217M | $-559M | $-1.19B | $636M | $19M | $1.08B | $79M | |
| Net Change in Cash | $-393M | $-167M | $860M | $-458M | $283M | $1.72B | $-418M | $-364M | $378M | $486M | $790M | $603M | |
| Taxes Paid | $275M | $379M | $405M | $340M | $235M | $321M | $239M | $240M | $7M | $153M | $197M | $30M | |
| Free Cash Flow | $-636M | $544M | $1.58B | $682M | $2.04B | $1.82B | $370M | $-344M | $718M | $497M | · | · | |
| Levered FCF | · | · | $1.50B | $600M | $1.95B | $1.74B | $304M | $-425M | $619M | $471M | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 12.8% | 13.7% | 13.3% | 9.1% | 9.4% | 10.6% | · | |
| Operating Margin | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% | 5.5% | 6.2% | 6.0% | -2.8% | 1.7% | 2.7% | 2.0% | |
| Net Margin | 1.0% | 2.9% | 3.2% | 2.5% | 2.4% | 3.5% | 4.4% | 3.7% | -2.6% | 0.29% | 1.0% | 0.64% | |
| Pretax Margin | 1.3% | 3.9% | 4.3% | 3.3% | 3.1% | 5.0% | 5.8% | 5.3% | -3.1% | 1.1% | 2.3% | 1.4% | |
| EBITDA Margin | 2.1% | 4.7% | 5.1% | 4.2% | 4.1% | 6.0% | 6.7% | 6.7% | -1.9% | 2.7% | 3.6% | 3.4% | |
| ROA | 3.0% | 7.7% | 8.0% | 6.5% | 6.1% | 8.2% | 10.6% | 9.0% | -6.4% | 0.74% | 2.6% | 1.7% | |
| ROE | 10.9% | 25.4% | 27.0% | 26.4% | 25.6% | 33.2% | 40.9% | 47.4% | -34.3% | 3.2% | 11.1% | 6.5% | |
| ROIC | 8.0% | 17.1% | 18.3% | 17.0% | 16.0% | 17.9% | 24.8% | 30.0% | -17.5% | 2.4% | 8.6% | 8.8% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 | 1.6 | 1.8 | 1.5 | 1.4 | 1.3 | 1.4 | 1.5 | |
| Quick Ratio | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 | 1.6 | 1.8 | 1.4 | 1.2 | 1.2 | 1.2 | 1.5 | |
| Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 1.0 | 0.3 | 0.0 | |
| LT Debt / Equity | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 | 1.0 | 0.6 | 0.6 | 1.0 | 0.7 | · | · | |
| Interest Coverage | · | · | 14.4 | 10.7 | 8.5 | 10.6 | 12.0 | 9.8 | -4.7 | 3.0 | 5.9 | 3.4 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.9 | 2.7 | 2.5 | 2.6 | 2.6 | 2.4 | 2.4 | 2.4 | 2.5 | 2.5 | 2.6 | 2.6 | |
| Receivables Turnover | 13.3 | 12.7 | 12.6 | 14.3 | 14.4 | 12.6 | 12.3 | 17.2 | 21.6 | 22.6 | 23.8 | 21.6 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $79.78 | $80.29 | $72.67 | $51.10 | · | $35.53 | $31.61 | $26.56 | $22.28 | $28.93 | $27.80 | $20.32 | |
| Revenue / Share | $858.71 | $704.51 | $586.44 | $546.56 | $473.91 | $323.72 | $262.95 | $283.63 | $355.05 | $317.54 | $253.18 | $199.97 | |
| Cash Flow / Share | $-10.11 | $11.16 | $28.61 | $13.21 | $36.16 | $31.50 | $6.67 | $-4.71 | $14.36 | $12.02 | $20.09 | $21.93 | |
| Cash / Share | $83.29 | $83.25 | $83.59 | $69.07 | · | $70.41 | $39.55 | $45.58 | $53.10 | $49.46 | $41.59 | $30.95 | |
| EPS (TTM) | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 | $11.23 | $11.47 | $10.61 | $-9.07 | $0.92 | $2.58 | $1.29 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 19.3% | 6.6% | 15.1% | 43.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.4% | 13.5% | 20.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -56.3% | 8.8% | 38.5% | 20.4% | 0.18% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -13.0% | 22.0% | 18.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -4.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -60.0% | 8.1% | 37.8% | 20.2% | -2.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.8% | 21.4% | 17.5% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -6.9% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B | $19.42B | $16.83B | $18.89B | $19.88B | $17.78B | $14.18B | $9.67B | |
| Net Income TTM | $472M | $1.18B | $1.09B | $792M | $659M | $673M | $737M | $707M | $-512M | $52M | $143M | $62M | |
| Market Cap | $8.85B | $16.30B | $20.96B | $19.15B | · | $12.55B | $8.41B | $7.21B | $4.60B | $3.09B | $3.37B | $2.66B | |
| Enterprise Value | $4.36B | $10.23B | $14.03B | $13.82B | · | $8.65B | $5.25B | $3.72B | $209M | $161M | $-314M | $104M | |
| P/E | 19.5 | 14.3 | 19.2 | 24.4 | 28.3 | 18.9 | 11.8 | 11.0 | -8.5 | 59.0 | 23.3 | 41.5 | |
| P/S | 0.2 | 0.4 | 0.6 | 0.6 | · | 0.6 | 0.5 | 0.4 | 0.2 | 0.2 | 0.2 | 0.3 | |
| P/B | 2.2 | 3.6 | 5.0 | 6.5 | · | 6.0 | 4.3 | 4.4 | 3.4 | 1.9 | 2.2 | 2.6 | |
| P / Tangible Book | 4.7 | 6.4 | 7.6 | 12.2 | · | 10.9 | · | · | · | · | · | · | |
| P / Cash Flow | -16.5 | 25.3 | 12.6 | 24.8 | · | 6.6 | 19.7 | -22.9 | 5.7 | 4.6 | 3.0 | 2.5 | |
| P / FCF | -13.9 | 30.0 | 13.3 | 28.1 | · | 6.9 | 22.7 | -20.9 | 6.4 | 6.2 | · | · | |
| EV / EBITDA | 4.5 | 5.4 | 8.0 | 10.2 | · | 7.4 | 4.6 | 3.0 | -0.6 | 0.3 | -0.6 | 0.3 | |
| EV / FCF | -6.9 | 18.8 | 8.9 | 20.3 | · | 4.8 | 14.2 | -10.8 | 0.3 | 0.3 | · | · | |
| EV / Revenue | 0.1 | 0.3 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.2 | 0.0 | 0.0 | -0.0 | 0.0 | |
| Earnings Yield | 5.1% | 7.0% | 5.2% | 4.1% | 3.5% | 5.3% | 8.5% | 9.1% | -11.8% | 1.7% | 4.3% | 2.4% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.87B | $10.80B | $11.38B | $11.48B | $11.43B | $11.15B | $10.50B | $10.34B | $9.88B | $9.93B | $9.05B | $8.55B | $8.33B | $8.15B | $8.22B | $7.93B | |
| Cost of Revenue | $9.44B | $9.27B | $10.14B | $10.04B | $9.83B | $9.48B | $9.00B | $8.64B | $8.37B | $8.41B | $7.45B | $7.31B | $7.04B | $6.87B | $6.99B | $6.75B | |
| SG&A Expense | $724M | $779M | $795M | $729M | $711M | $774M | $665M | $676M | $691M | $711M | $645M | $608M | $618M | $591M | $629M | $560M | |
| Operating Expenses | $10.73B | $10.71B | $11.54B | $11.34B | $11.05B | $10.71B | $10.12B | $9.87B | $9.45B | $9.51B | $8.73B | $8.19B | $7.88B | $7.69B | $8.12B | $7.59B | |
| Operating Income | $145M | $83M | $-162M | $137M | $373M | $433M | $380M | $467M | $434M | $426M | $316M | $359M | $443M | $455M | $105M | $335M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $27M | · | $27M | $27M | $28M | · | $28M | |
| Interest Income | · | · | · | · | · | · | · | $20M | $21M | $22M | · | $20M | $19M | $21M | · | $19M | |
| Other Non-op | · | · | · | · | · | · | · | · | $-28M | $-27M | · | $-27M | $-27M | $-28M | · | $-28M | |
| Pretax Income | $91M | $29M | $-214M | $88M | $325M | $390M | $346M | $438M | $406M | $399M | $289M | $332M | $416M | $427M | $78M | $307M | |
| Income Tax | $31M | $15M | $-54M | $9M | $70M | $92M | $95M | $112M | $105M | $98M | $73M | $87M | $107M | $106M | $22M | $77M | |
| Net Income | $60M | $14M | $-160M | $79M | $255M | $298M | $251M | $326M | $301M | $301M | $216M | $245M | $309M | $321M | $56M | $230M | |
| EPS (Basic) | $1.19 | $0.27 | $-2.80 | $1.51 | $4.75 | $5.47 | $4.46 | $5.67 | $5.18 | $5.21 | $3.72 | $4.24 | $5.37 | $5.58 | $0.98 | $4.00 | |
| EPS (Diluted) | $1.19 | $0.27 | $-2.79 | $1.51 | $4.75 | $5.45 | $4.43 | $5.65 | $5.17 | $5.17 | $3.69 | $4.21 | $5.35 | $5.52 | $0.96 | $3.95 | |
| Shares (Basic) | 51,100,000 | 50,900,000 | · | 52,500,000 | 53,600,000 | 54,600,000 | · | 57,600,000 | 58,100,000 | 57,900,000 | · | 57,800,000 | 57,700,000 | 57,500,000 | · | 57,600,000 | |
| Shares (Diluted) | 51,300,000 | 51,000,000 | · | 52,500,000 | 53,700,000 | 54,800,000 | · | 57,700,000 | 58,200,000 | 58,300,000 | · | 58,100,000 | 57,900,000 | 58,000,000 | · | 58,300,000 | |
| EBITDA | $145M | $122M | · | $137M | $373M | $481M | · | $467M | $434M | $471M | · | $359M | $443M | $499M | · | $335M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.99B | $5.31B | $4.25B | $4.22B | $4.50B | $4.86B | $4.66B | $4.73B | $4.35B | $4.51B | $4.85B | $5.57B | $4.91B | $4.55B | $4.01B | $4.24B | |
| Short-term Investments | $3.93B | $3.94B | $4.01B | $4.23B | $4.31B | $4.44B | $4.33B | $4.48B | $4.35B | $4.42B | · | $4.11B | $3.89B | $3.81B | · | $3.64B | |
| Receivables | $3.48B | $3.42B | $3.53B | $3.52B | $3.87B | $3.49B | $3.30B | $3.26B | $3.23B | $3.35B | · | $2.46B | $2.38B | $2.54B | · | $2.22B | |
| Prepaid Expense | $528M | $655M | $655M | $590M | $438M | $472M | $487M | $408M | $399M | $381M | · | $332M | $260M | $259M | · | $391M | |
| Current Assets | $12.93B | $13.33B | $12.44B | $12.55B | $13.11B | $13.26B | $12.77B | $12.88B | $12.33B | $12.67B | · | $12.47B | $11.44B | $11.16B | · | $10.49B | |
| PP&E (Gross) | · | · | $1.11B | · | · | · | $1.03B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $875M | · | · | · | $806M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | $1.96B | · | · | · | $1.67B | · | · | · | $1.24B | · | · | · | $1.11B | · | |
| Intangibles | · | · | $237M | · | · | · | $267M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $140M | $146M | $147M | $142M | $148M | $163M | $138M | $132M | $136M | $134M | · | $125M | $118M | $119M | · | $186M | |
| Total Assets | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Accounts Payable | $1.14B | $1.16B | $1.09B | $1.12B | $1.11B | $1.12B | $1.33B | $1.22B | $973M | $1.11B | · | $1.09B | $857M | $787M | · | $818M | |
| Current Liabilities | $7.70B | $8.19B | $7.37B | $7.48B | $7.88B | $8.15B | $7.90B | $8.34B | $7.84B | $8.51B | · | $8.49B | $7.54B | $7.61B | · | $7.24B | |
| Capital Leases | · | · | $56M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $179M | $176M | $173M | $174M | $167M | $155M | $120M | $122M | $122M | $124M | · | $121M | $122M | $88M | · | $118M | |
| Total Liabilities | $11.83B | $12.31B | $11.49B | $11.51B | $11.61B | $12.08B | $11.13B | $10.99B | $10.34B | $11.02B | · | $10.99B | $10.04B | $10.08B | · | $9.75B | |
| Total Debt | $3.77B | $3.77B | · | $3.66B | $3.38B | $3.57B | · | $2.33B | $2.18B | $2.18B | · | $2.18B | $2.18B | $2.18B | · | $2.17B | |
| Retained Earnings | $3.68B | $3.62B | $3.60B | $3.76B | $4.16B | $3.90B | $4.09B | $4.33B | $4.49B | $4.19B | · | $3.67B | $3.43B | $3.12B | · | $2.94B | |
| AOCI | $-16M | $-7M | $15M | $9M | $-10M | $-28M | $-57M | $-9M | $-85M | $-85M | · | $-165M | $-146M | $-125M | · | $-185M | |
| Stockholders' Equity | $4.17B | $4.08B | $4.07B | $4.19B | $4.60B | $4.31B | $4.50B | $4.77B | $4.84B | $4.49B | $4.21B | $3.88B | $3.62B | $3.29B | $2.96B | $3.04B | |
| Liabilities + Equity | $16.00B | $16.39B | $15.56B | $15.70B | $16.21B | $16.39B | $15.63B | $15.76B | $15.19B | $15.51B | · | $14.87B | $13.66B | $13.37B | · | $12.79B | |
| Shares Outstanding | 52,000,000 | 52,000,000 | 51,000,000 | 51,000,000 | 54,000,000 | 54,000,000 | 56,000,000 | 57,000,000 | 59,000,000 | 59,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 | 58,000,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $40M | $39M | $44M | $45M | $58M | $48M | $48M | $47M | $46M | $45M | $43M | $42M | $42M | $44M | $47M | $45M | |
| Stock-based Comp | $26M | $33M | $20M | $-3M | $3M | $27M | $18M | $30M | $32M | $36M | $27M | $33M | $30M | $25M | $23M | $23M | |
| Other Non-cash | · | $996M | · | · | · | $-183M | · | · | · | $-168M | · | · | · | $526M | · | · | |
| Operating Cash Flow | $-294M | $1.08B | $-298M | $-125M | $-302M | $190M | $-224M | $873M | $-219M | $214M | $-690M | $949M | $487M | $916M | $-212M | $254M | |
| CapEx | $30M | $27M | $-1M | $38M | $42M | $22M | $11M | $35M | $27M | $27M | $-5M | $26M | $31M | $32M | $10M | $31M | |
| Investing Cash Flow | $-30M | $11M | $230M | $77M | $128M | $-123M | $19M | $-48M | $53M | $-488M | $-25M | $-280M | $-137M | $-302M | $148M | $-347M | |
| Stock Repurchased | $0 | $0 | $0 | $500M | $0 | $500M | $500M | $500M | $0 | $0 | $0 | $0 | · | · | $200M | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-500M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-4M | $-20M | $92M | $-220M | $-189M | $147M | $67M | $-364M | $12M | $-62M | $3M | $-6M | $10M | $-65M | $-183M | $10M | |
| Net Change in Cash | $-328M | $1.07B | $24M | $-268M | $-363M | $214M | $-138M | $461M | $-154M | $-336M | $-712M | $663M | $360M | $549M | $-247M | $-83M | |
| Free Cash Flow | · | $1.05B | · | · | · | $168M | · | · | · | $187M | · | · | · | $884M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $167M | · | · | · | $863M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 1.3% | 0.77% | · | 1.2% | 3.3% | 3.9% | · | 4.5% | 4.4% | 4.3% | · | 4.2% | 5.3% | 5.6% | · | 4.2% | |
| Net Margin | 0.55% | 0.13% | · | 0.69% | 2.2% | 2.7% | · | 3.1% | 3.0% | 3.0% | · | 2.9% | 3.7% | 3.9% | · | 2.9% | |
| Pretax Margin | 0.84% | 0.27% | · | 0.77% | 2.8% | 3.5% | · | 4.2% | 4.1% | 4.0% | · | 3.9% | 5.0% | 5.2% | · | 3.9% | |
| EBITDA Margin | 1.3% | 1.1% | · | 1.2% | 3.3% | 4.3% | · | 4.5% | 4.4% | 4.7% | · | 4.2% | 5.3% | 6.1% | · | 4.2% | |
| ROA | 0.37% | 0.09% | · | 0.50% | 1.6% | 1.9% | · | 2.1% | 2.1% | 2.1% | · | 1.8% | 2.4% | 2.5% | · | 1.9% | |
| ROE | 1.4% | 0.33% | · | 1.8% | 5.4% | 6.8% | · | 7.5% | 7.1% | 7.7% | · | 7.1% | 9.6% | 10.6% | · | 8.3% | |
| ROIC | 1.2% | 0.51% | · | 1.6% | 3.7% | 4.2% | · | 4.9% | 4.6% | 4.8% | · | 4.4% | 5.7% | 6.3% | · | 4.8% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.6 | · | 1.7 | 1.7 | 1.6 | · | 1.5 | 1.6 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.6 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 | |
| Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.9 | 0.9 | · | 0.9 | 0.7 | 0.8 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 15.8 | · | 13.3 | 16.4 | 16.2 | · | 12.0 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.7 | |
| Receivables Turnover | 3.0 | 3.1 | · | 3.4 | 3.2 | 3.3 | · | 3.6 | 3.5 | 3.4 | · | 3.7 | 3.6 | 3.5 | · | 3.8 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $80.21 | $78.46 | · | $82.18 | $85.24 | $79.81 | · | $83.68 | $82.08 | $76.15 | · | $66.88 | $62.43 | $56.69 | · | $52.43 | |
| Revenue / Share | $211.97 | $211.69 | · | $218.61 | $212.79 | $203.41 | · | $179.20 | $169.76 | $170.34 | · | $147.13 | $143.82 | $140.50 | · | $135.97 | |
| Cash Flow / Share | · | $21.22 | · | · | · | $3.47 | · | · | · | $3.67 | · | · | · | $15.79 | · | · | |
| Cash / Share | $95.87 | $102.19 | · | $82.76 | $83.31 | $89.93 | · | $83.02 | $73.80 | $76.49 | · | $95.95 | $84.66 | $78.52 | · | $73.14 | |
| EPS (TTM) | $0.18 | $3.74 | · | $16.14 | $20.28 | $20.70 | · | $19.68 | $18.24 | $18.42 | · | $16.04 | $15.78 | $14.68 | · | $14.33 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $44.52B | $45.08B | · | $44.55B | $43.41B | $41.87B | · | $39.20B | $37.41B | $35.85B | · | $33.25B | $32.63B | $32.35B | · | $31.16B | |
| Net Income TTM | $-7M | $188M | · | $883M | $1.13B | $1.18B | · | $1.14B | $1.06B | $1.07B | · | $931M | $916M | $855M | · | $839M | |
| Market Cap | $11.89B | $6.93B | · | $9.76B | $16.09B | $17.79B | · | $19.64B | $17.54B | $24.24B | · | $19.02B | $17.47B | $15.51B | · | $19.13B | |
| Enterprise Value | $6.75B | $1.45B | · | $4.98B | $10.65B | $12.07B | · | $12.76B | $11.02B | $17.48B | · | $11.52B | $10.85B | $9.33B | · | $13.42B | |
| P/E | 1270.6 | 35.6 | · | 11.9 | 14.7 | 15.9 | · | 17.5 | 16.3 | 22.3 | · | 20.4 | 19.1 | 18.2 | · | 23.0 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.7 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | |
| P/B | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Tangible Book | 2.9 | 1.7 | · | 2.3 | 3.5 | 4.1 | · | 4.1 | 3.6 | 5.4 | · | 4.9 | 4.8 | 4.7 | · | 6.3 | |
| P / Cash Flow | · | 6.4 | · | · | · | 93.6 | · | · | · | 113.3 | · | · | · | 16.9 | · | · | |
| EV / Revenue | 0.2 | 0.0 | · | 0.1 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.5 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| Earnings Yield | 0.08% | 2.8% | · | 8.4% | 6.8% | 6.3% | · | 5.7% | 6.1% | 4.5% | · | 4.9% | 5.2% | 5.5% | · | 4.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $45.43B | $40.65B | $34.07B | $31.97B | $27.77B |
| Margen Operativo % | 1.7% | 4.2% | 4.6% | 3.7% | 3.7% |
| Beneficio neto | $472M | $1.18B | $1.09B | $792M | $659M |
| EPS Diluido | $8.92 | $20.42 | $18.77 | $13.55 | $11.25 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.9 | 0.7 | 0.5 | 0.7 | 0.8 |
| Ratio corriente | 1.7 | 1.6 | 1.5 | 1.5 | 1.4 |
| Ratio Rápido | 1.6 | 1.6 | 1.5 | 1.4 | 1.4 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-636M | $544M | $1.58B | $682M | $2.04B |
Propietarios institucionales (13F) 673 declarantes · $13.8B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 159 (+18 vs trimestre anterior) | 68 (-75 vs trimestre anterior) | 219 (+23 vs trimestre anterior) | 181 (+8 vs trimestre anterior) | +1.1M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $1 503 052 088 | 6 572 156 | 10,91% | Acciones |
| VANGUARD GROUP INC | $1 055 736 837 | 6 083 536 | 7,66% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $806 903 452 | 3 560 601 | 5,86% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $638 128 574 | 2 790 243 | 4,63% | Acciones |
| Capital World Investors | $586 138 203 | 2 562 913 | 4,26% | Acciones |
| Lingotto Investment Management LLP | $574 377 763 | 2 511 490 | 4,17% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $538 648 191 | 2 355 261 | 3,91% | Acciones |
| FMR LLC | $427 964 063 | 1 871 290 | 3,11% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $427 014 918 | 1 867 140 | 3,10% | Acciones |
| STATE STREET CORP | $401 475 303 | 1 755 467 | 2,91% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $318 659 985 | 1 393 338 | 2,31% | Acciones |
| GOLDMAN SACHS GROUP INC | $298 810 862 | 1 306 563 | 2,17% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $289 810 242 | 1 267 207 | 2,10% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $289 611 501 | 1 266 338 | 2,10% | Acciones |
| Capital Research Global Investors | $249 797 804 | 1 092 251 | 1,81% | Acciones |
| MORGAN STANLEY | $230 316 927 | 1 007 068 | 1,67% | Acciones |
| HARRIS ASSOCIATES L P | $218 980 250 | 957 500 | 1,59% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $204 005 369 | 891 772 | 1,48% | Acciones |
| 8 KNOTS MANAGEMENT, LLC | $198 942 438 | 1 146 378 | 1,44% | Acciones |
| MANNING & NAPIER ADVISORS LLC | $152 338 582 | 663 669 | 1,11% | Acciones |
| UBS Group AG | $142 749 967 | 624 180 | 1,04% | Acciones |
| Long Focus Capital Management, LLC | $139 507 000 | 610 000 | 1,01% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $131 512 792 | 575 045 | 0,95% | Acciones |
| TWO SIGMA ADVISERS, LP | $116 582 437 | 671 790 | 0,85% | Acciones |
| Invesco Ltd. | $116 332 600 | 508 669 | 0,84% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $115 548 617 | 505 241 | 0,84% | Acciones |
| NORTHERN TRUST CORP | $88 292 838 | 386 064 | 0,64% | Acciones |
| NORGES BANK | $87 054 426 | 380 649 | 0,63% | Acciones |
| Bank of New York Mellon Corp | $86 138 019 | 376 642 | 0,63% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82 789 400 | 362 000 | 0,60% | Opción de venta |
| BNP PARIBAS FINANCIAL MARKETS | $82 559 556 | 360 995 | 0,60% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $75 497 758 | 330 117 | 0,55% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $72 051 935 | 315 050 | 0,52% | Acciones |
| BANK OF AMERICA CORP /DE/ | $71 479 956 | 312 549 | 0,52% | Acciones |
| Amundi | $59 944 786 | 262 111 | 0,44% | Acciones |
| PRINCIPAL FINANCIAL GROUP INC | $57 795 692 | 252 714 | 0,42% | Acciones |
| Maple Rock Capital Partners Inc. | $55 642 710 | 243 300 | 0,40% | Acciones |
| Russell Investments Group, Ltd. | $53 133 740 | 232 165 | 0,39% | Acciones |
| INVESTMENT MANAGEMENT ASSOCIATES INC /ADV | $52 660 005 | 230 258 | 0,38% | Acciones |
| STATE OF MICHIGAN RETIREMENT SYSTEM | $51 238 863 | 224 044 | 0,37% | Acciones |
| D. E. Shaw & Co., Inc. | $47 575 775 | 208 027 | 0,35% | Acciones |
| CITIGROUP INC | $47 390 070 | 207 215 | 0,34% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46 357 490 | 202 700 | 0,34% | Opción de compra |
| REDWOOD CAPITAL MANAGEMENT, LLC | $45 740 000 | 200 000 | 0,33% | Acciones |
| DEUTSCHE BANK AG\ | $45 272 766 | 197 957 | 0,33% | Acciones |
| INVESTMENT HOUSE LLC | $44 310 854 | 193 751 | 0,32% | Acciones |
| JANE STREET GROUP, LLC | $43 224 300 | 189 000 | 0,31% | Opción de venta |
| Fiera Capital Corp | $43 130 075 | 188 588 | 0,31% | Acciones |
| Summit Street Capital Management, LLC | $41 630 489 | 182 031 | 0,30% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $41 211 511 | 180 199 | 0,30% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Mary R. Molina Living Trust, Exempt Mary R. Molina Living Trust, Mary R. Molina Grantor Retained Annuity Trust 609/4, Mary R. Molina Grantor Retained Annuity Trust 609/7, Mary R. Molina Grantor Retained Annuity Trust 1209/3, Mary R. Molina Grantor Retained Annuity Trust 1209/4, Mary R. Molina Grantor Retained Annuity Trust 610/4, Mary R. Molina Grantor Retained Annuity Trust 610/5, Mary R. Molina Grantor Retained Annuity Trust 1210/4, Mary R. Molina Grantor Retained Annuity Trust 811/3, Mary R. Molina Grantor Retained Annuity Trust 812/3, Estate of Mary R. Molina, Dentino Family Trust, Curtis and Rosi Pedersen 2012 Trust, William Dentino, Curtis Pedersen ×3 presentaciones | 23 de enero de 2018 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 62 insiders · 25 directivos · 19 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Roman Kulich | Pres & CEO of Molina of MI | 22 de agosto de 2007 S | 5 734 | 0 | 0 | $0 |
| Gerald Landgraf | CEO/Pres of Molina of NM | 1 de julio de 2005 A | · | 0 | 0 | $0 |
| Mark Lowell Keim | Chief Financial Officer | 1 de marzo de 2026 A | 83 251 | 0 | 0 | $0 |
| Joseph W White CPA | Former Chief Financial Officer | 6 de junio de 2018 D | 48 390 | 0 | 0 | $0 |
| James Woys | Chief Operating Officer | 30 de junio de 2026 A | 90 178 | 0 | 0 | $0 |
| Terry Bayer | Chief Operating Officer | 2 de febrero de 2018 D | 28 730 | 0 | 0 | $0 |
| Debra Bacon | EVP, Medicaid | 1 de julio de 2026 F | 21 636 | 0 | 0 | $0 |
| Jeff D. Barlow | Chief Legal Officer | 30 de junio de 2026 A | 67 313 | 0 | 1 | $-3 314 983 |
| Marc Russo | EVP, Health Plans | 7 de agosto de 2023 S | 37 093 | 0 | 0 | $0 |
| Pamela Sedmak | Executive Vice President | 1 de marzo de 2020 F | 8 846 | 0 | 0 | $0 |
| Lisa A Rubino | Senior Vice President | 1 de marzo de 2018 F | 25 084 | 0 | 0 | $0 |
| Keith Wilson | Chief Medical Officer | 30 de junio de 2017 A | 29 441 | 0 | 0 | $0 |
| Amir Desai | Chief Information Officer | 16 de agosto de 2010 S | 16 782 | 0 | 0 | $0 |
| Mark L Andrews ESQ | Exec. VP, General Counsel | 1 de julio de 2010 F | 51 006 | 0 | 0 | $0 |
| Mary Martha Bernadett MD | Exec. V.P., Research | 5 de diciembre de 2008 J | 50 000 | 0 | 0 | $0 |
| Stephen T O'Dell | Regional Vice President | 7 de agosto de 2008 F | 16 199 | 0 | 0 | $0 |
| Lillis Ann Koontz | Regional Vice President | 30 de junio de 2008 A | 15 304 | 0 | 0 | $0 |
| George Kirk Olsen | VP, Molina Advantage | 29 de junio de 2007 A | 7 822 | 0 | 0 | $0 |
| Michael M Siegel | Chief Medical Officer | 1 de marzo de 2007 A | 5 150 | 0 | 0 | $0 |
| Rick Click | Chief Information Officer | 1 de marzo de 2007 A | 8 500 | 0 | 0 | $0 |
| Harvey A Fein | VP, Internal Auditing | 1 de marzo de 2007 A | 8 713 | 0 | 0 | $0 |
| Joann Zarza-Garrido | VP, Compliance | 28 de febrero de 2007 S | 4 774 | 0 | 0 | $0 |
| William Bracciodieta | Former Chief Medical Officer | 16 de febrero de 2007 F | 5 000 | 0 | 0 | $0 |
| Sheila Shapiro | Exec. VP, Shared Services | 30 de diciembre de 2005 J | 12 564 | 0 | 0 | $0 |
| Jennings Patricia Dinsmore | VP Qual. Op. & Integration | 16 de agosto de 2004 S | 0 | 0 | 0 | $0 |
| Stephen H Lockhart | Consejero | 1 de octubre de 2026 A | 4 688 | 0 | 0 | $0 |
| Richard M Schapiro | Consejero | 1 de octubre de 2026 A | 12 615 | 0 | 1 | $-51 058 |
| Richard C Zoretic | Consejero | 1 de octubre de 2026 A | 9 693 | 1 | 0 | $100 128 |
| Leo P Grohowski | Consejero | 1 de octubre de 2026 A | 1 846 | 0 | 0 | $0 |
| Francis S Soistman JR | Consejero | 1 de octubre de 2026 A | 1 211 | 0 | 0 | $0 |
| Dale B Wolf | Consejero | 1 de octubre de 2026 A | 15 937 | 0 | 0 | $0 |
| Steven J Orlando | Consejero | 1 de octubre de 2026 A | 18 271 | 0 | 0 | $0 |
| Ronna Romney | Consejero | 1 de octubre de 2026 A | 18 173 | 0 | 1 | $-74 342 |
| Barbara L Brasier | Consejero | 1 de octubre de 2026 A | 6 122 | 0 | 0 | $0 |
| Daniel Cooperman | Consejero | 1 de abril de 2025 A | 6 383 | 0 | 0 | $0 |
| Garrey Carruthers | Consejero | 1 de abril de 2021 A | 5 265 | 0 | 0 | $0 |
| Charles Z Fedak | Consejero | 1 de abril de 2019 A | 19 092 | 0 | 0 | $0 |
| John C Molina | Consejero | 20 de febrero de 2018 S | 372 930 | 0 | 0 | $0 |
| Frank E Murray MD | Consejero | 1 de octubre de 2017 A | 16 811 | 0 | 0 | $0 |
| Steven James | Consejero | 1 de abril de 2016 A | 15 024 | 0 | 0 | $0 |
| John P Szabo JR | Consejero | 1 de abril de 2015 A | 17 097 | 0 | 0 | $0 |
| Sally K Richardson | Consejero | 3 de mayo de 2012 A | 47 537 | 0 | 0 | $0 |
| Wayne B Lowell | Consejero | 10 de mayo de 2007 A | 10 011 | 0 | 0 | $0 |
| Ronald Cpa Dba Lossett | Consejero | 10 de febrero de 2004 A | · | 0 | 0 | $0 |
| MARY R MOLINA LIVING TRUST | Propietario del 10% | 14 de diciembre de 2009 J | 2 137 134 | 0 | 0 | $0 |
| MOLINA MARITAL TRUST | Propietario del 10% | 22 de junio de 2006 S | 2 926 907 | 0 | 0 | $0 |
| Maurice Hebert | · | 14 de mayo de 2026 S | 12 815 | 0 | 1 | $-114 930 |
| Joseph M Zubretsky | · | 1 de marzo de 2026 A | 99 015 | 0 | 0 | $0 |
| Thomas L Tran | · | 24 de mayo de 2021 F | 29 775 | 0 | 0 | $0 |
| Norman Nichols | · | 8 de agosto de 2018 S | 47 415 | 0 | 0 | $0 |
| Harold Gooch | · | 30 de junio de 2018 A | 7 063 | 0 | 0 | $0 |
| Mario J Molina MD | · | 11 de diciembre de 2017 S | 61 125 | 0 | 0 | $0 |
| James W Howatt | · | 19 de marzo de 2010 S | 34 081 | 0 | 0 | $0 |
| Curtis Pedersen | · | 5 de noviembre de 2009 G | 1 200 | 0 | 0 | $0 |
| Josephine M Molina | · | 6 de agosto de 2008 J | 345 701 | 0 | 0 | $0 |
| Janet M Watt | · | 6 de agosto de 2008 J | 284 641 | 0 | 0 | $0 |
| Josephine M Battiste | · | 6 de agosto de 2008 J | 345 701 | 0 | 0 | $0 |
| Zarina Sparling | · | 21 de febrero de 2008 M | 9 380 | 0 | 0 | $0 |
| Mary R Molina | · | 27 de septiembre de 2006 J | 0 | 0 | 0 | $0 |
| George S Goldstein PHD | · | 11 de mayo de 2006 M | 0 | 0 | 0 | $0 |
| Richard A Helmer MD | · | 30 de junio de 2005 J | 1 908 | 0 | 0 | $0 |
| David W Erickson | · | 2 de diciembre de 2004 M | 0 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 73 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| SOVF · Elevation Series Trust | 4,23% | 18 894 NS | 31 de julio de 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 1,81% | 120 017 SH | 1 de octubre de 2026 | Diario |
| RFV · Invesco Exchange-Traded Fund Trust | 1,77% | 29 907 SH | 1 de octubre de 2026 | Diario |
| IHF · iShares Trust | 1,53% | 100 080 SH | 11 de septiembre de 2026 | Diario |
| VIOV · VANGUARD ADMIRAL FUNDS | 1,28% | 110 553 SH | 19 de agosto de 2026 | Diario |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,76% | 5 983 000 | 1 de octubre de 2026 | Diario |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,64% | 182 154 SH | 19 de agosto de 2026 | Diario |
| FFLV · FIDELITY COVINGTON TRUST | 0,41% | 343 NS | 31 de julio de 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,40% | 6 790 NS | 31 de julio de 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,33% | 7 103 SH | 1 de octubre de 2026 | Diario |
| DFAT · Dimensional ETF Trust | 0,27% | 198 247 NS | 31 de julio de 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,26% | 8 610 NS | 31 de julio de 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,25% | 758 589 SH | 19 de agosto de 2026 | Diario |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 22 626 NS | 31 de julio de 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,22% | 765 NS | 31 de julio de 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,20% | 3 918 NS | 31 de julio de 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,18% | 156 577 SH | 19 de agosto de 2026 | Diario |
| ESML · iShares Trust | 0,17% | 23 899 SH | 11 de septiembre de 2026 | Diario |
| IYH · iShares Trust | 0,17% | 30 059 SH | 11 de septiembre de 2026 | Diario |
| DFSV · Dimensional ETF Trust | 0,16% | 67 624 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,16% | 7 446 SH | 11 de septiembre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,15% | 24 870 NS | 31 de julio de 2026 | N-PORT |
| SMMD · iShares Trust | 0,14% | 27 458 SH | 11 de septiembre de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,14% | 1 195 007 SH | 19 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,13% | 597 850 SH | 19 de agosto de 2026 | Diario |
| IWS · iShares Trust | 0,10% | 77 233 SH | 11 de septiembre de 2026 | Diario |
| WSML · iShares Trust | 0,10% | 3 305 SH | 11 de septiembre de 2026 | Diario |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,10% | 4 920 SH | 1 de octubre de 2026 | Diario |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 3 768 SH | 1 de octubre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,09% | 68 863 NS | 31 de julio de 2026 | N-PORT |
| IWR · iShares Trust | 0,08% | 210 604 SH | 11 de septiembre de 2026 | Diario |
| PRF · Invesco Exchange-Traded Fund Trust | 0,07% | 35 013 SH | 1 de octubre de 2026 | Diario |
| EMGF · iShares, Inc. | 0,06% | 15 805 SH | 11 de septiembre de 2026 | Diario |
| DXUV · Dimensional ETF Trust | 0,05% | 1 409 NS | 31 de julio de 2026 | N-PORT |
| EMXC · iShares, Inc. | 0,05% | 162 911 SH | 11 de septiembre de 2026 | Diario |
| DFSU · Dimensional ETF Trust | 0,04% | 5 157 NS | 31 de julio de 2026 | N-PORT |
| VEGN · ETF Series Solutions | 0,03% | 305 NS | 31 de julio de 2026 | N-PORT |
| IUSV · iShares Trust | 0,03% | 45 470 SH | 11 de septiembre de 2026 | Diario |
| IEMG · iShares, Inc. | 0,03% | 689 771 SH | 11 de septiembre de 2026 | Diario |
| EEM · iShares, Inc. | 0,03% | 131 827 SH | 11 de septiembre de 2026 | Diario |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 31 058 SH | 19 de agosto de 2026 | Diario |
| IWD · iShares Trust | 0,03% | 114 206 SH | 11 de septiembre de 2026 | Diario |
| DFUV · Dimensional ETF Trust | 0,03% | 20 443 NS | 31 de julio de 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,03% | 52 472 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,02% | 2 686 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 1 655 258 SH | 19 de agosto de 2026 | Diario |
| VWO · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 868 836 SH | 19 de agosto de 2026 | Diario |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 8 548 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 4 354 SH | 19 de agosto de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,02% | 11 634 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,02% | 45 023 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 2 946 NS | 31 de julio de 2026 | N-PORT |
| IXUS · iShares Trust | 0,02% | 126 782 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,01% | 14 718 SH | 11 de septiembre de 2026 | Diario |
| IWB · iShares Trust | 0,01% | 35 396 SH | 11 de septiembre de 2026 | Diario |
| IYY · iShares Trust | 0,01% | 2 168 SH | 11 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,01% | 15 184 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 67 059 SH | 11 de septiembre de 2026 | Diario |
| DFAU · Dimensional ETF Trust | 0,01% | 8 285 NS | 31 de julio de 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,01% | 531 000 SH | 11 de septiembre de 2026 | Diario |
| VOXP · Advisors Series Trust | 0,01% | 3 NS | 31 de julio de 2026 | N-PORT |
| ACWX · iShares Trust | 0,01% | 16 724 SH | 11 de septiembre de 2026 | Diario |
| VXUS · VANGUARD STAR FUNDS | 0,01% | 910 737 SH | 19 de agosto de 2026 | Diario |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 145 760 SH | 19 de agosto de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 89 282 SH | 19 de agosto de 2026 | Diario |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,01% | 68 906 SH | 19 de agosto de 2026 | Diario |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 2 303 SH | 1 de octubre de 2026 | Diario |
| ACWI · iShares Trust | 0,00% | 8 307 SH | 11 de septiembre de 2026 | Diario |
| IJH · iShares Trust | · | 1 828 162 SH | 11 de septiembre de 2026 | Diario |
| IJJ · iShares Trust | · | 265 658 SH | 21 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 2 352 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 6 481 SH | 11 de septiembre de 2026 | Diario |
| SMMV · iShares Trust | · | 4 872 SH | 1 de septiembre de 2026 | Diario |
MOH Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
Precio objetivo a 12 meses
17 analistas · 2026-09-30Objetivo medio $209.12 +10,3%
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.